Patient-Reported Outcomes in Neurology and Psychiatry

Articles (7 in this collection)

1. Evaluation of Individual Items of the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) in Adults with Treatment-Resistant Depression Treated with Esketamine Nasal Spray Combined with a New Oral Antidepressant

   Authors (first, second and last of 7)

   • Lysbeth Floden
   • Stacie Hudgens
   • Jaskaran Singh

   • Content type: Original Research Article
   • Open Access
   • Published: 20 April 2022

   • Pages: 649 - 658

   

2. Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study

   Authors (first, second and last of 11)

   • Giovanni Castelnovo
   • Oliver Gerlach
   • Joep Killestein

   • Content type: Original Research Article
   • Open Access
   • Published: 28 July 2021

   • Pages: 1009 - 1022

   

3. Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients’ Perspectives

   Authors (first, second and last of 38)

   • Laurent M. Willems
   • Felix Rosenow
   • Adam Strzelczyk

   • Content type: Original Research Article
   • Open Access
   • Published: 17 July 2021

   • Pages: 1107 - 1122

   

4. Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report

   Authors (first, second and last of 15)

   • Emma Morton
   • Venkat Bhat
   • the CAN-BIND Investigator Team

   • Content type: Original Research Article
   • Published: 16 April 2021

   • Pages: 439 - 450

5. Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies

   Authors (first, second and last of 5)

   • Joost J. Breeksema
   • Alistair R. Niemeijer
   • Robert A. Schoevers

   • Content type: Systematic Review
   • Open Access
   • Published: 17 August 2020

   • Pages: 925 - 946

   

6. Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine

   Authors (first, second and last of 14)

   • Jeremy Hobart
   • Tjalf Ziemssen
   • On behalf of the ENHANCE study investigators

   • Content type: Original Research Article
   • Open Access
   • Published: 10 December 2018

   • Pages: 61 - 79

   

7. Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years Later

   Authors

   • A. George Awad

   • Content type: Current Opinion
   • Published: 03 December 2018

   • Pages: 1 - 8